Tag: FVT TRI TDS

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC

Clinical efficacy and safety data will be presented from over 70 small-cell lung cancer (SCLC) patients in Hengrui's ongoing, multi-site, open label Phase 1...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsFVT TRI TDS

Weekly share repurchase program transaction details

[Latest] Global Information Services Market Size/Share Worth USD 327.94 Billion by 2034 at a 6.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends,...

Q2 2025 turnover

Tag: FVT TRI TDS

IDEAYA Biosciences and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us